Spots Global Cancer Trial Database for Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)
Official Title: Influence on Hemostasis During Prolonged Asparaginase Treatment in Childhood and Adolescent ALL
Study ID: NCT01094392
Conditions
Interventions
Study Description
Brief Summary: Asparaginase is an important drug in the treatment of childhood leukemia. One of the rare but severe side effects to the treatment is thrombosis in or outside the central nervous system. The aim of this study is to investigate and describe the influence on the coagulation parameters during prolonged treatment with asparaginase. Hopefully this knowledge will help to foresee the risk of thrombosis and thus making it possible to prevent these.
Detailed Description:
Eligibility
Minimum Age: 1 Year
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Aalborg Hospital, Aalborg, , Denmark
Department of Pediatrics, Skejby Hospital, Aarhus, , Denmark
Department of Pediatrics, Rigshospitalet, Copenhagen, , Denmark
University Hospital in Odense, Odense, , Denmark
Contact Details
Name: Birgitte K Albertsen, Ph.D. M.D.
Affiliation: Department of Pediatrics, Skejby Hospital, Aarhus, Denmark
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
